Literature DB >> 22240242

Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases.

Jia-Ming Xu1, Guo-Ping Shi.   

Abstract

Mast cells are essential in allergic immune responses. Recent discoveries have revealed their direct participation in cardiovascular diseases and metabolic disorders. Although more sophisticated mechanisms are still unknown, data from animal studies suggest that mast cells act similarly to macrophages and other inflammatory cells and contribute to human diseases through cell-cell interactions and the release of proinflammatory cytokines, chemokines, and proteases to induce inflammatory cell recruitment, cell apoptosis, angiogenesis, and matrix protein remodeling. Reduced cardiovascular complications and improved metabolic symptoms in animals receiving over-the-counter antiallergy medications that stabilize mast cells open another era of mast cell biology and bring new hope to human patients suffering from these conditions.
Copyright © 2012 by The Endocrine Society

Entities:  

Mesh:

Year:  2012        PMID: 22240242      PMCID: PMC3365842          DOI: 10.1210/er.2011-0013

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  406 in total

1.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

2.  Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions.

Authors:  Erietta Stelekati; Rajia Bahri; Orietta D'Orlando; Zane Orinska; Hans-Willi Mittrücker; Rabea Langenhaun; Markus Glatzel; Annalena Bollinger; Ralf Paus; Silvia Bulfone-Paus
Journal:  Immunity       Date:  2009-10-08       Impact factor: 31.745

3.  A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels.

Authors:  Mami Ikenoya; Yasunobu Yoshinaka; Hideyuki Kobayashi; Katsumi Kawamine; Kimiyuki Shibuya; Fumiyasu Sato; Kimio Sawanobori; Takuya Watanabe; Akira Miyazaki
Journal:  Atherosclerosis       Date:  2006-07-03       Impact factor: 5.162

4.  Comparison of histamine release from peritoneal mast cells derived from diabetic and control rats.

Authors:  M Ennis; E R Trimble
Journal:  Agents Actions       Date:  1991-05

5.  Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase.

Authors:  Rampura T Venkatesha; E Berla Thangam; Asifa K Zaidi; Hydar Ali
Journal:  Mol Immunol       Date:  2005-03       Impact factor: 4.407

6.  A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha.

Authors:  Takayoshi Suganami; Junko Nishida; Yoshihiro Ogawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

7.  Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.

Authors:  Fiona Y Chow; David J Nikolic-Paterson; Elyce Ozols; Robert C Atkins; Gregory H Tesch
Journal:  J Am Soc Nephrol       Date:  2005-04-27       Impact factor: 10.121

8.  Analyses of cancer data from three ezetimibe trials.

Authors:  Richard Peto; Jonathan Emberson; Martin Landray; Colin Baigent; Rory Collins; Robert Clare; Robert Califf
Journal:  N Engl J Med       Date:  2008-09-02       Impact factor: 91.245

9.  Pulmonary CXCR2 regulates VCAM-1 and antigen-induced recruitment of mast cell progenitors.

Authors:  Jenny Hallgren; Tatiana G Jones; J Pablo Abonia; Wei Xing; Alison Humbles; K Frank Austen; Michael F Gurish
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-10       Impact factor: 11.205

10.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

View more
  39 in total

Review 1.  Advances in understanding mechanisms and therapeutic targets to treat comorbid depression and cardiovascular disease.

Authors:  Brittany S Pope; Susan K Wood
Journal:  Neurosci Biobehav Rev       Date:  2020-06-26       Impact factor: 8.989

2.  Leptin Deficiency Shifts Mast Cells toward Anti-Inflammatory Actions and Protects Mice from Obesity and Diabetes by Polarizing M2 Macrophages.

Authors:  Yi Zhou; Xueqing Yu; Huimei Chen; Sara Sjöberg; Joséphine Roux; Lijun Zhang; Al-Habib Ivoulsou; Farid Bensaid; Cong-Lin Liu; Jian Liu; Joan Tordjman; Karine Clement; Chih-Hao Lee; Gokhan S Hotamisligil; Peter Libby; Guo-Ping Shi
Journal:  Cell Metab       Date:  2015-10-17       Impact factor: 27.287

3.  Moderate alcohol induces stress proteins HSF1 and hsp70 and inhibits proinflammatory cytokines resulting in endotoxin tolerance.

Authors:  Sujatha Muralidharan; Aditya Ambade; Melissa A Fulham; Janhavee Deshpande; Donna Catalano; Pranoti Mandrekar
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

Review 4.  Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes.

Authors:  Vivekanandhan Aravindhan; Gowrishankar Anand
Journal:  Am J Trop Med Hyg       Date:  2017-10-26       Impact factor: 2.345

5.  Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.

Authors:  Jing Wang; Sara Sjöberg; Viviane Tia; Blandine Secco; Han Chen; Min Yang; Galina K Sukhova; Guo-Ping Shi
Journal:  Atherosclerosis       Date:  2013-06-07       Impact factor: 5.162

6.  Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice.

Authors:  Jie Zhang; Huimei Chen; Li Liu; Jiusong Sun; Michael A Shi; Galina K Sukhova; Guo-Ping Shi
Journal:  Cardiovasc Res       Date:  2012-08-07       Impact factor: 10.787

Review 7.  Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.

Authors:  Aina He; Guo-Ping Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Enhanced vascular chymase-dependent conversion of endothelin in the diabetic kidney.

Authors:  Lisa M Harrison-Bernard; Lawrence de Garavilla; Benjamin J Bivona
Journal:  Ochsner J       Date:  2013

Review 9.  Mast cell chymase and tryptase in abdominal aortic aneurysm formation.

Authors:  Yi Wang; Guo-Ping Shi
Journal:  Trends Cardiovasc Med       Date:  2012-08-14       Impact factor: 6.677

Review 10.  Mast cells in human and experimental cardiometabolic diseases.

Authors:  Guo-Ping Shi; Ilze Bot; Petri T Kovanen
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.